This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Experts
Brenda Brewer
Associate Director
Contact
BrendaBrewer@westat.comOverview
Brenda Brewer is an Associate Director for Clinical Research. Her clinical research experience focuses on cancer intervention and screening trials as well as infectious disease. She has also led international in-country assessments of the marketing by baby food companies in India, Thailand, and Nigeria. This research has led to more effective cancer screening guidelines for lung cancer, and it helps to prevent and evaluate therapies for HIV and other emerging infectious diseases. This works supports studies of the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and nonprofit organizations.
Education
- MMSc, Allied Health, Emory University
- BS, Nutrition, Texas Tech University
-
Journal Article
Vaccine effectiveness against influenza-associated urgent care, emergency department, and hospital encounters during the 2021–2022 season, VISION NetworkJournal of Infectious Diseases
2023
M.W. Tenforde, Z.A. Weber, M.B. DeSilva, E. Stenehjem, D.-H. Yang, B. Fireman, M. Gaglani, N. Kojima, S.A. Irving, S. Rao, S.J. Grannis, A.L. Naleway, L. Kirshner, A.B. Kharbanda, K. Dascomb, N. Lewis, A.F. Dalton, Sarah Ball, K. Natarajan, T.
-
Journal Article
Smokeless tobacco use and prevalence of cardiovascular disease among males in the Population Assessment of Tobacco and Health (PATH) Study, Waves 1–4Preventive Medicine Reports
2022
G.J. Nahhas, K.M. Cummings, M.J. Halenar, E. Sharma, A.J. Alberg, D. Hatuskami, M. Bansal-Travers, A. Hyland, D.E. Gaalema, P.B. Morris, K. Duffy, J.T. Chang, G. Lagaud, J.C. Vivar, D. Marshall, C. Blanco, Kristie Taylor
SOURCE -
Journal Article
Gynecologic oncologist impact on adjuvant chemotherapy care for stage II-IV ovarian cancer patientsGynecologic Oncology
2022
K.S. Weeks, C.F. Lynch, M. West, R. Carnahan, M. O'Rorke, J. Oleson, M. McDonald, S.L. Stewart, L.L. Hunter, S.-M. Lai, S. Garimella, J. Keighley, L. Huang, J. Jackson-Thompson, N. Hunt Rold, C.L. Schmaltz, S. Yemane, W. Ross, Diane Ng, M. Traverso-Ortiz
SOURCE